{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:53:16Z","timestamp":1790448796373,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/bmt.2015.330","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T14:53:26Z","timestamp":1452524006000},"page":"553-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"51","author":[{"given":"Y","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Okinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-W","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tanosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"BFbmt2015330_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1200\/JCO.2010.32.5001","volume":"29","author":"JT Horan","year":"2011","unstructured":"Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK et al. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J Clin Oncol 2011; 29: 805\u2013813.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015330_CR2","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091\u20132101.","journal-title":"N Engl J Med"},{"key":"BFbmt2015330_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/bmt.2012.172","volume":"48","author":"S Kurosawa","year":"2013","unstructured":"Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H et al. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia\/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone Marrow Transplant 2013; 48: 529\u2013536.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005; 36: 757\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR5","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.bbmt.2011.05.001","volume":"17","author":"M Remberger","year":"2011","unstructured":"Remberger M, Ackefors M, Berglund S, Blennow O, Dahllof G, Dlugosz A et al. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant 2011; 17: 1688\u20131697.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.bbmt.2014.04.021","volume":"20","author":"F Malard","year":"2014","unstructured":"Malard F, Chevallier P, Guillaume T, Delaunay J, Rialland F, Harousseau JL et al. Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution's three decade experience. Biol Blood Marrow Transplant 2014; 20: 1217\u20131223.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/bmt.2013.42","volume":"48","author":"S Kurosawa","year":"2013","unstructured":"Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H et al. Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplant 2013; 48: 1198\u20131204.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628\u20131633.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15: 367\u2013369.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR10","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt2015330_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","volume":"144","author":"T Parimon","year":"2006","unstructured":"Parimon T, Au D, Martin P, Chien J . A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006; 144: 407\u2013414.","journal-title":"Ann Intern Med"},{"key":"BFbmt2015330_CR13","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BFbmt2015330_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452\u2013458.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR15","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","volume":"110","author":"SJ Lee","year":"2007","unstructured":"Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576\u20134583.","journal-title":"Blood"},{"key":"BFbmt2015330_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bmt.1704596","volume":"34","author":"M Yanada","year":"2004","unstructured":"Yanada M, Emi N, Naoe T, Sakamaki H, Takahashi S, Hirabayashi N et al. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan. Bone Marrow Transplant 2004; 34: 331\u2013337.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbmt.2003.12.304","volume":"10","author":"PJ Martin","year":"2004","unstructured":"Martin PJ, McDonald GB, Sanders JE, Anasetti C, Appelbaum FR, Deeg HJ et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004; 10: 320\u2013327.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/bmt.2010.112","volume":"46","author":"DD Poutsiaka","year":"2011","unstructured":"Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR . Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 2011; 46: 300\u2013307.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood.V84.4.1328.1328","volume":"84","author":"H Sayer","year":"1994","unstructured":"Sayer H, Longton G, Bowden R, Pepe M, Storb R . Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 1994; 84: 1328\u20131332.","journal-title":"Blood"},{"key":"BFbmt2015330_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/422009","volume":"190","author":"K Marr","year":"2004","unstructured":"Marr K, Balajee S, McLaughlin L, Tabouret M, Bentsen C, Walsh T . Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641\u2013649.","journal-title":"J Infect Dis"},{"key":"BFbmt2015330_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/510592","volume":"44","author":"A Upton","year":"2007","unstructured":"Upton A, Kirby K, Carpenter P, Boeckh M, Marr K . Invasive Aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531\u2013540.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015330_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1702805","volume":"27","author":"Y Kanda","year":"2001","unstructured":"Kanda Y, Mineishi S, Saito T, Seo S, Saito A, Suenaga K et al. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan. Bone Marrow Transplant 2001; 27: 437\u2013444.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bpa.2008.06.005","volume":"22","author":"AM Shilling","year":"2008","unstructured":"Shilling AM, Raphael J . Diabetes, hyperglycemia, and infections. Best Pract Res Clin Anaesthesiol 2008; 22: 519\u2013535.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"BFbmt2015330_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/bmt.2008.431","volume":"44","author":"S Fuji","year":"2009","unstructured":"Fuji S, Kim SW, Mori S, Kamiya S, Yoshimura K, Yokoyama H et al. Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study. Bone Marrow Transplant 2009; 44: 105\u2013111.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015330_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","volume":"21","author":"S Arai","year":"2015","unstructured":"Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2015; 21: 266\u2013274.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbmt.2013.10.014","volume":"20","author":"T Ruutu","year":"2014","unstructured":"Ruutu T, Juvonen E, Remberger M, Remes K, Volin L, Mattsson J et al. Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study. Biol Blood Marrow Transplant 2014; 20: 135\u2013138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","volume":"13","author":"J Tay","year":"2007","unstructured":"Tay J, Tinmouth A, Fergusson D, Huebsch L, Allan DS . Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 206\u2013217.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015330_CR28","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1182\/blood-2011-06-358010","volume":"118","author":"J Magenau","year":"2011","unstructured":"Magenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P et al. Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies. Blood 2011; 118: 4258\u20134264.","journal-title":"Blood"},{"key":"BFbmt2015330_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/leu.2012.352","volume":"27","author":"H Pfeifer","year":"2013","unstructured":"Pfeifer H, Wassmann B, Bethge W, Dengler J, Bornhauser M, Stadler M et al. Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia 2013; 27: 1254\u20131262.","journal-title":"Leukemia"},{"key":"BFbmt2015330_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/ejh.12336","volume":"93","author":"M Bastos-Oreiro","year":"2014","unstructured":"Bastos-Oreiro M, Perez-Corral A, Martinez-Laperche C, Bento L, Pascual C, Kwon M et al. Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation. Eur J Haematol 2014; 93: 239\u2013246.","journal-title":"Eur J Haematol"},{"key":"BFbmt2015330_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/leu.2011.234","volume":"26","author":"U Platzbecker","year":"2012","unstructured":"Platzbecker U, Wermke M, Radke J, Oelschlaegel U, Seltmann F, Kiani A et al. Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. Leukemia 2012; 26: 381\u2013389.","journal-title":"Leukemia"},{"key":"BFbmt2015330_CR32","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbmt.2011.08.011","volume":"18","author":"P Kebriaei","year":"2012","unstructured":"Kebriaei P, Saliba R, Rondon G, Chiattone A, Luthra R, Anderlini P et al. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes. Biol Blood Marrow Transplant 2012; 18: 584\u2013592.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015330","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:08:58Z","timestamp":1648062538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFbmt2015330"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.330","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]},"assertion":[{"value":"27 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}